Searched over 200M research papers for "cancer people"
10 papers analyzed
These studies suggest that the most prevalent cancers in the US are prostate, breast, and colon/rectum, with increasing survivorship but persistent racial disparities in treatment and outcomes.
20 papers analyzed
The number of cancer survivors in the United States has been steadily increasing due to advancements in early detection and treatment, as well as the aging and growth of the population. As of January 1, 2019, there were more than 16.9 million Americans with a history of cancer, a number projected to exceed 22.1 million by 2030. By January 1, 2022, this number had already surpassed 18 million. This trend underscores the importance of addressing the unique medical and psychosocial needs of cancer survivors.
The most prevalent cancers among males in 2019 were prostate, colon and rectum, and melanoma of the skin, while among females, breast, uterine corpus, and colon and rectum cancers were most common. By 2022, the most prevalent cancers among males remained prostate and melanoma of the skin, with colon and rectum cancers still significant, whereas among females, breast, uterine corpus, and thyroid cancers were most prevalent.
A significant portion of cancer survivors were diagnosed within the past decade, with more than half of survivors diagnosed in the last 10 years . Additionally, a large majority of survivors are aged 65 years or older, highlighting the intersection of cancer survivorship with aging .
Racial disparities in cancer treatment and outcomes remain a critical issue. For instance, Black patients with stage I rectal cancer are less likely to receive surgical treatment compared to White patients, and similar disparities exist for non-small cell lung cancer. Furthermore, Black men have a higher incidence and mortality rate for several cancers compared to White men, and Black women face higher mortality rates for breast and endometrial cancers despite similar or lower incidence rates.
Cancer patients, especially those with advanced disease, often experience a range of symptoms that significantly impair their quality of life. Common issues include pain, fatigue, anxiety, depression, and other physical and emotional challenges. Palliative care has been recognized as a vital component of cancer care, addressing these complex needs and improving the quality of life for patients and their families.
The increasing number of cancer survivors presents both opportunities and challenges for the healthcare system. While advancements in detection and treatment have improved survival rates, there is a pressing need to address the unique medical and psychosocial needs of survivors, reduce racial disparities in treatment and outcomes, and enhance palliative care services. Continued investment in research, education, and equitable access to resources is essential to optimize care for all individuals affected by cancer.
Most relevant research papers on this topic